Topic: Partnering and Collaborations with Biopharma Industry
Parth Chakrabarti, VP of Business Development at Vertex Pharmaceuticals, will be covering partnerships and alliances for life science startups. This will be an excellent opportunity to ask questions and openly discuss strategies for building R&D partnerships, alliances, licensing deals as a life science startup with large biopharma corporations. We will touch on how interact with potential partners, when to reach out, the different types of alliances, typical deal structures & terms, what to expect when negotiating and closing a deal, and developing an execution strategy.
Speaker Bio: Parth Chakrabarti, MBA is the Vice President of Business Development at Vertex Pharmaceuticals and possess over two decades of biopharma experience. Parth is an expert in structuring, negotiating, and closing deals across multiple different therapeutic areas and a variety of different deal types. Deals led by Parth resulted in the creation of new business units, platforms, and TAs, and covered by Wall Street Journal and FierceBiotech, among other prominent publications. Prior to Vertex, Parth was the Global Head of Business Development – Immunology & Neuroscience at Sanofi, as well as holding senior roles at Johnson & Johnson and Baxter. Parth was trained in Medicinal Chemistry & Pharmacy, and received his MBA from Wharton, and his MPH from Harvard.
About the Workshop Series: This series of workshops is for early-stage life science founders from the Harvard Innovation Labs ecosystem. The workshop will focus specifically on business development, commercialization strategy, and product development strategy for life sciences and healthcare markets. Topics will include prioritization of indications/applications, competitor landscape analyses, intellectual property strategy, regulatory & payer/reimbursement strategy, partnerships & alliances with industry, and venture financing & fundraising strategy. The workshop will bring together founders in an informal setting with leaders from life science startups, industry, and venture capital for group discussions on these different topics. The series will include ‘homework’ given to the founders, which will then be shared and discussed with the group as a means to gain feedback and insights into other founder’s learning experiences. The workshop series will also serve the purpose of promoting a strong sense of community among the founders, allowing them to help one another through the challenges experienced as early-stage life science founders.
